Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Asian Patients: A 10-year Experience in a Single Institution

被引：0
|
作者：
Tan, G. [1 ]
Teo, M. [1 ]
Chan, W. [1 ]
Soo, K. [1 ]
机构：
[1] Natl Canc Ctr Singapore, Singapore, Singapore
来源：
ANNALS OF SURGICAL ONCOLOGY | 2012年 / 19卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S135 / S136
页数：2
相关论文
共 50 条
  • [31] Robotic-assisted cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (CRS-HIPEC)
    Emmanuel Gabriel
    Enrique Elli
    Sanjay Bagaria
    Nabil Wasif
    Travis Grotz
    John Stauffer
    Pashtoon M. Kasi
    Horacio Asbun
    Journal of Robotic Surgery, 2019, 13 : 175 - 179
  • [32] Outcome of Icelandic patients undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS-HIPEC) abroad
    Petursdottir, Astriour
    Gunnarsson, Orvar
    Valsdottir, Elsa B.
    LAEKNABLADID, 2020, 106 (7-8): : 344 - 348
  • [33] Significance of Urinary Tract Involvement in Patients Treated with Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC)
    Konstantinos I. Votanopoulos
    Reese W. Randle
    Brandon Craven
    Katrina R. Swett
    Edward A. Levine
    Perry Shen
    John H. Stewart
    Majid Mirzazadeh
    Annals of Surgical Oncology, 2014, 21 : 868 - 874
  • [34] Significance of Urinary Tract Involvement in Patients Treated with Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC)
    Votanopoulos, Konstantinos I.
    Randle, Reese W.
    Craven, Brandon
    Swett, Katrina R.
    Levine, Edward A.
    Shen, Perry
    Stewart, John H.
    Mirzazadeh, Majid
    ANNALS OF SURGICAL ONCOLOGY, 2014, 21 (03) : 868 - 874
  • [35] Improved Survival with Experience: A 10-Year Learning Curve in Hyperthermic Intraperitoneal Chemotherapy and Cytoreductive Surgery
    Natasha L. Leigh
    Daniel Solomon
    Daniela Feingold
    Deepa R. Magge
    Benjamin J. Golas
    Umut Sarpel
    Daniel M. Labow
    Annals of Surgical Oncology, 2020, 27 : 222 - 231
  • [36] Improved Survival with Experience: A 10-Year Learning Curve in Hyperthermic Intraperitoneal Chemotherapy and Cytoreductive Surgery
    Leigh, Natasha L.
    Solomon, Daniel
    Feingold, Daniela
    Magge, Deepa R.
    Golas, Benjamin J.
    Sarpel, Umut
    Labow, Daniel M.
    ANNALS OF SURGICAL ONCOLOGY, 2020, 27 (01) : 222 - 231
  • [37] The impact of urological resection and reconstruction on patients undergoing cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC)
    Tan, Grace Hwei Ching
    Shannon, Nicholas B.
    Chia, Claramae Shulyn
    Lee, Lui Shiong
    Soo, Khee Chee
    Teo, Melissa Ching Ching
    ASIAN JOURNAL OF UROLOGY, 2018, 5 (03) : 194 - 198
  • [38] Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy (CRS-HIPEC) of Extraperitoneal Abdominal Disease, Is it Appropriate?
    Mangieri, Chris W.
    Votanopoulos, Konstantinos
    Shen, Perry
    Levine, Edward
    ANNALS OF SURGICAL ONCOLOGY, 2024, 31 (01) : S36 - S36
  • [39] Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy (CRS-HIPEC) of Extraperitoneal Abdominal Disease, is it Appropriate?
    Mangieri, Christopher W.
    Votanopoulos, Konstantinos I.
    Shen, Perry
    Levine, Edward A.
    ANNALS OF SURGICAL ONCOLOGY, 2025, 32 (04) : 2893 - 2902
  • [40] OUTCOMES OF CYTOREDUCTIVE SURGERY AND HYPERTHERMIC INTRAPERITONEAL CHEMOTHERAPY (CRS/HIPEC) IN THE TREATMENT OF PRIMARY PERITONEAL CARCINOMA
    Sardi, A.
    Diaz-Montes, T.
    Sipok, A.
    Sittig, M.
    Nieroda, C.
    Gushchin, V.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2016, 26 : 679 - 679
12345